Kotak Alternate Asset Managers logo

Kotak Alternate Asset Managers

Asia, Maharashtra, India, Mumbai

Description

Kotak Alternate Asset Managers focuses exclusively on managing the alternate assets business of the Kotak Mahindra Group.

Investor Profile

Kotak Alternate Asset Managers has backed more than 9 startups, with 6 new investments in the last 12 months alone. The firm has led 5 rounds, about 56% of its total and boasts 8 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Private Equity, Debt Financing rounds (top funding stages).
  • Majority of deals are located in India, United States.
  • Strong thematic focus on Health Care, Biotechnology, Wellness.
  • Led 4 rounds in the past year.

Stage Focus

  • Series A (56%)
  • Private Equity (22%)
  • Debt Financing (11%)
  • Secondary Market (11%)

Country Focus

  • India (89%)
  • United States (11%)

Industry Focus

  • Health Care
  • Biotechnology
  • Wellness
  • Life Science
  • Diabetes
  • Insurtech
  • Medical Device
  • Personal Health
  • Commercial Real Estate
  • Financial Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kotak Alternate Asset Managers frequently co-invest with?

SH
North America, Michigan, United States, Ann Arbor
Co-Investments: 1
Mayfield Fund
North America, California, United States, Menlo Park
Co-Investments: 1
Elevation Capital
Asia, Haryana, India, Gurgaon
Co-Investments: 1
Capital 2B
Asia, Delhi, India, Delhi
Co-Investments: 2
Gemba Capital
Asia, Karnataka, India, Bangalore
Co-Investments: 1
Accel
North America, California, United States, Palo Alto
Co-Investments: 1
Gruhas
Asia, Karnataka, India, Bangalore
Co-Investments: 1
1Crowd
Asia, Maharashtra, India, Mumbai
Co-Investments: 2
W Health Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
LetsVenture
Asia, Karnataka, India, Bengaluru
Co-Investments: 1

Which angels does Kotak Alternate Asset Managers often collaborate with?

Nimesh Kampani
Asia, Maharashtra, India, Mumbai
Shared Deals: 1

What are some of recent deals done by Kotak Alternate Asset Managers?

Avammune Therapeutics

Philadelphia, Pennsylvania, United States

Avammune Therapeutics is a drug discovery company.

BiotechnologyTherapeutics
Series AMay 7, 2025
Amount Raised: $12,000,000
Ace Designers

Bangalore, Karnataka, India

Ace Designers is a CNC machine maker.

IndustrialMachinery ManufacturingManufacturing
Private EquityApr 30, 2025
Amount Raised: $141,883,382
Tirupati Group

New Delhi, Delhi, India

Tirupati Group provides pharmaceutical and health care solutions.

Health CareLife SciencePharmaceutical
Secondary MarketMar 26, 2025
Amount Raised: $122,592,379
Neuberg Diagnostics

Chennai, Tamil Nadu, India

Neuberg Diagnostics encouraging customers to become more conscious of their surroundings and make healthier decisions.

Health CareHealth DiagnosticsMedical
Private EquityJan 10, 2025
Amount Raised: $109,473,967
Ahammune Biosciences

Pune, Maharashtra, India

Ahammune Biosciences is an innovation-led drug discovery company.

BiotechnologyHealth CareLife Science
Series ASep 25, 2024
Amount Raised: $5,000,000
Nutrabay

New Delhi, Delhi, India

Nutrabay is a D2C multi-brand nutrition store that provides an online platform to sell nutritional supplements.

E-CommerceFitnessHealth CareWellness
Series ASep 2, 2024
Amount Raised: $5,000,000
BeatO

New Delhi, Delhi, India

BeatO is a developer of a health monitoring application that helps diabetic patients track their glucose levels.

DiabetesHealth CareInsurTechMedical DevicePersonal HealthWellness
Debt FinancingApr 27, 2022
Amount Raised: $3,530,748
Strata

Bengaluru, Karnataka, India

Strata is a fractional real estate investment platform that makes investing in premium commercial properties easy, transparent, & affordable

Commercial Real EstateFinancial ServicesReal Estate Investment
Series AJul 29, 2021
Amount Raised: $6,000,000
Mynvax

Bangalore, Karnataka, India

Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza.

BiotechnologyHealth Care
Series AJul 19, 2021
Amount Raised: $4,133,689